{"doi":"10.3389/fonc.2024.1395502","title":"Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting","abstract":"Quantitative dynamic contrast-enhanced (DCE) MRI as a promising method for the prediction of breast cancer response to neoadjuvant chemotherapy (NAC) has been demonstrated mostly in single-center and single-vendor platform studies. This preliminary study reports the initial experience in implementing quantitative breast DCE-MRI in multi-center (MC) and multi-vendor platform (MP) settings to predict NAC response. MRI data, including B 1 mapping, variable flip angle (VFA) measurements of native tissue R 1 (R 1,0 ), and DCE-MRI, were acquired during NAC at three sites using 3T systems with Siemens, Philips, and GE platforms, respectively. High spatiotemporal resolution DCE-MRI was performed using similar vendor product sequences with k-space undersampling during acquisition and view sharing during reconstruction. A breast phantom was used for quality assurance/quality control (QA/QC) across sites. The Tofts model (TM) and shutter-speed model (SSM) were used for pharmacokinetic (PK) analysis of the DCE data. Additionally, tumor region of interest (ROI)- vs . voxel-based analyses in combination with the use of VFA-measured R 1,0 vs . fixed, literature-reported R 1,0 were investigated to determine the optimal analysis approach. Results from 15 patients who completed the study are reported. Voxel-based PK analysis using fixed R 1,0 was deemed the optimal approach, which allowed the inclusion of data from one vendor platform where VFA measurements produced ≥100% overestimation of R 1,0 . The semi-quantitative signal enhancement ratio (SER) and quantitative PK parameters outperformed the tumor longest diameter (LD) in the prediction of pathologic complete response (pCR) vs. non-pCR after the first NAC cycle, whereas K trans consistently provided more accurate predictions than both SER and LD after the first NAC cycle and at the NAC midpoint. Both TM and SSM K trans and k ep were excellent predictors of response at the NAC midpoint with ROC AUC &amp;gt;0.90, while the SSM parameters (AUC ≥0.80) performed better than their TM counterparts (AUC &amp;lt;0.80) after the first NAC cycle. The initial experience of this ongoing study indicates the importance of QA/QC using a phantom and suggests that deploying voxel-based PK analysis using a fixed R 1,0 may mitigate random errors from R 1,0 measurements across platforms and potentially eliminate the need for B 1 and VFA acquisitions in MC and MP trials.","journal":"Frontiers in Oncology","year":2024,"id":451059,"datarank":0.24141568686511508,"base_score":1.6094379124341003,"endowment":1.6094379124341003,"self_citation_contribution":0.24141568686511508,"citation_network_contribution":0.0,"self_endowment_contribution":0.24141568686511508,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":4,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.96,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":383811,"name":"Xin Li","orcid":"0000-0002-9283-3602","position":1,"is_corresponding":false},{"id":639355,"name":"Michael Hirano","orcid":null,"position":2,"is_corresponding":false},{"id":1272019,"name":"Assim Saad Eddin","orcid":"0009-0000-8769-7311","position":3,"is_corresponding":false},{"id":568120,"name":"Jeong Youn Lim","orcid":null,"position":4,"is_corresponding":false},{"id":1029768,"name":"Debosmita Biswas","orcid":"0000-0002-0798-5637","position":5,"is_corresponding":false},{"id":789803,"name":"Anum S. Kazerouni","orcid":"0000-0002-4200-534X","position":6,"is_corresponding":false},{"id":296781,"name":"Alina Tudorica","orcid":null,"position":7,"is_corresponding":false},{"id":324318,"name":"Isabella Li","orcid":"0009-0007-1571-9244","position":8,"is_corresponding":false},{"id":1030335,"name":"Mary Lynn Bryant","orcid":null,"position":9,"is_corresponding":false},{"id":1272494,"name":"Courtney Wille","orcid":null,"position":10,"is_corresponding":false},{"id":928236,"name":"Chelsea Pyle","orcid":null,"position":11,"is_corresponding":false},{"id":294005,"name":"Habib Rahbar","orcid":"0000-0003-4835-1478","position":12,"is_corresponding":false},{"id":1272495,"name":"Su Kim Hsieh","orcid":null,"position":13,"is_corresponding":false},{"id":458130,"name":"Travis Rice‐Stitt","orcid":null,"position":14,"is_corresponding":false},{"id":347082,"name":"Suzanne M. Dintzis","orcid":"0000-0001-9762-030X","position":15,"is_corresponding":false},{"id":769178,"name":"Amani Bashir","orcid":"0000-0002-7239-3662","position":16,"is_corresponding":false},{"id":1272020,"name":"Evthokia Hobbs","orcid":"0000-0002-7738-0131","position":17,"is_corresponding":false},{"id":242493,"name":"Alexandra S. Zimmer","orcid":"0000-0001-6789-0982","position":18,"is_corresponding":false},{"id":232692,"name":"Jennifer M. Specht","orcid":"0000-0003-1484-2113","position":19,"is_corresponding":false},{"id":970048,"name":"Sneha Phadke","orcid":"0000-0002-9829-1066","position":20,"is_corresponding":false},{"id":1272021,"name":"Nicole Margo Grogan Fleege","orcid":"0000-0001-9268-7070","position":21,"is_corresponding":false},{"id":545600,"name":"James H. Holmes","orcid":"0000-0002-0936-3700","position":22,"is_corresponding":false},{"id":294006,"name":"Savannah C. Partridge","orcid":"0000-0001-6370-9111","position":23,"is_corresponding":false},{"id":1272022,"name":"Wei Huang","orcid":"0000-0002-3468-7467","position":24,"is_corresponding":false},{"id":306501,"name":"Brendan Moloney","orcid":null,"position":0,"is_corresponding":true}],"reference_count":46,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:02:41.417944Z","pmid":"39678499","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}